Audrey Le Formal

MET Is a Potential Target across All Papillary Renal Cell Carcinomas: Result from a Large Molecular Study of pRCC with CGH Array and Matching Gene Expression Array

Laurence Albigès, Justine Guégan, Audrey Le Formal et al. · Clinical Cancer Research · 2014 · 171 citations

Neoadjuvant chemotherapy (NACT) increases immune infiltration and programmed death-ligand 1 (PD-L1) expression in epithelial ovarian cancer (EOC)

Soizick Mesnage, Aurélie Auguste, Catherine Genestie et al. · Annals of Oncology · 2016 · 171 citations · Full text

Cancer Immunosurveillance, Neoadjuvant Chemotherapy, Epithelial Ovarian Cancer +12

Refinement of high-risk endometrial cancer classification using DNA damage response biomarkers: a TransPORTEC initiative

Aurélie Auguste, Catherine Genestie, Marco de Bruyn et al. · Modern Pathology · 2018 · 60 citations · Full text

Biomarker (Medicine), Prognostic Biomarkers, Oncology +9

Small Cell Carcinoma of the Ovary, Hypercalcemic Type (SCCOHT) beyond SMARCA4 Mutations: A Comprehensive Genomic Analysis

Aurélie Auguste, Félix Blanc‐Durand, Marc Deloger et al. · Cells · 2020 · 55 citations · Full text

Changes in DNA Damage Response Markers with Treatment in Advanced Ovarian Cancer

Paul Kubelac, Catherine Genestie, Aurélie Auguste et al. · Cancers · 2020 · 51 citations · Full text